Attitudes and opinion about adverse drug events of women living in a city of South Italy

Pharmacology

Volumn 91, Issue 3-4, 2013, Pages 173-177

  Salvo, Francesco ^a,b   Miroddi, Marco ^c   Alibrandi, Angela ^d   Calapai, Fabrizio ^c   Cafeo, Viviana ^c   Mancari, Ferdinando ^c   Gangemi, Sebastiano ^c   Caputi, Achille P ^c   Calapai, Gioacchino ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM U657   (France)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Adverse drug event; Adverse drug reaction; Pharmacovigilance; Phone survey; Risk perception; Women

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; CARDIOVASCULAR AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; ALLERGIC DISEASE; ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO HEALTH; COMORBIDITY; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; EDUCATIONAL STATUS; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH PRACTITIONER; HUMAN; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; NUTRITIONAL INTOLERANCE; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; EDUCATION PROGRAM; HEALTH SURVEY; LIFESTYLE MODIFICATION; MALAISE; MIDDLE AGED; PATIENT RISK; RISK FACTOR; STRUCTURED QUESTIONNAIRE; TELEPHONE INTERVIEW; TIME PERCEPTION; WORK EXPERIENCE; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; CITIES; COMPLEMENTARY THERAPIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERSENSITIVITY; ITALY; MIDDLE AGED; QUESTIONNAIRES; RISK; YOUNG ADULT;

EID: 84874008822     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000346737     Document Type: Article

References (20)

1. Montastuc JL, Bongard V, Lapeyre-Mestre M: Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal antiinflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists. Eur J Clin Pharmacol 2003; 59: 685-688
2. Cullen G, Kelly E, Murray FE: Patients' knowledge of adverse reactions to current medications. Br J Clin Pharmacol 2006; 62: 232-236
3. Krska J, Anderson C, Murphy E, Avery AJ: How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme. Drug Saf 2011; 34: 429-436
4. McLernon DJ, Bond CM, Lee AJ, Watson MC, Hannaford PC, Fortnum H, Krska J, Anderson C, Murphy E, Avery A: Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf 2011; 20: 523-531
5. Blenkinsopp A, Wilkie P, Wang M, Routledge PA: Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63: 148-156
6. de Langen J, van Hunsel F, Passier A, de Jongvan den Berg L, van Grootheest K: Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008; 31: 515-524
7. Aagaard L, Nielsen LH, Hansen EH: Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009; 32: 1067-1074
8. Durrieu G, Hurault C, Bongard V, Damase- Michel C, Montastruc JL: Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course. Br J Clin Pharmacol 2007; 64: 233-236
9. Bongard V, Menard-Tache S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL: Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. Br J Clin Pharmacol 2002; 54: 433-436
10. Tharpe N: Adverse drug reactions in women's health care. J Midwifery Womens Health 2011; 56: 205-213
11. Rademaker M: Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349-351
12. Nebeker JR, Barach P, Samore MH: Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801
13. Hammond I, Rich D: Consumers usurp spontaneous adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 2005; 14(suppl 2):S8-S9
14. Begaud B, Martin K, Fourrier A, Haramburu F: Does age increase the risk of adverse drug reactions? Br J Clin Pharmacol 2002; 54: 550- 552
15. Pouyanne P, Haramburu F, Imbs JL, Begaud B: Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036
16. Lopez L, Weissman JS, Schneider EC, Weingart SN, Cohen AP, Epstein AM: Disclosure of hospital adverse events and its association with patients' ratings of the quality of care. Arch Intern Med 2009; 169: 1888-1894
17. Gangemi S, Guarneri C, Romeo P, Guarneri F: Safety and reliability of the drug tolerance test: our experience in 739 patients. Pharmacology 2011; 87: 90-95
18. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15- 19
19. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M: Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 2009; 4:e4439
20. Hanley MJ, Abernethy DR, Greenblatt DJ: Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010; 49: 71-87